OBJECTIVE: To evaluate the long-term outcome of children following admission to a paediatric intensive care unit. DESIGN: Prospective, long-term follow-up study. SETTING: Sixteen-bed multi-disciplinary paediatric intensive care unit in a free-standing, university, tertiary, teaching hospital. PATIENTS: All children consecutively admitted to the paediatric intensive care unit from 1(st) January, 1995, to 31(st) December, 1995. INTERVENTIONS: Outcome was evaluated, by telephone interview, at a median of 3.5 years (range 2.3-6 years) after admission to the intensive care unit using a modification of the Glasgow Outcome Score (GOS) to assess functional outcome and the Health State Utility Index (Mark 1) to assess quality of life. MEASUREMENTS AND MAIN RESULTS: Of the children admitted to the intensive care unit, 83.8% were alive at the time of follow-up. While 10.3% of the survivors had an unfavourable outcome and were likely to live dependent on care, 89.7% had a favourable outcome and were likely to lead an independent existence. Although 16.4% had an unfavourable quality of life, 83.6% of the children survived with a favourable quality of life. At the time of follow-up, 16.2% of the children were dead: 49% died in the intensive care unit, 5% died in hospital and 46% died after discharge from hospital. CONCLUSIONS: The majority of children admitted to a paediatric intensive care unit survive with an excellent functional outcome and quality of life. Long-term outcome assessment provides a basis for observing trends in outcome over time within the same institution.
OBJECTIVE: To evaluate the long-term outcome of children following admission to a paediatric intensive care unit. DESIGN: Prospective, long-term follow-up study. SETTING: Sixteen-bed multi-disciplinary paediatric intensive care unit in a free-standing, university, tertiary, teaching hospital. PATIENTS: All children consecutively admitted to the paediatric intensive care unit from 1(st) January, 1995, to 31(st) December, 1995. INTERVENTIONS: Outcome was evaluated, by telephone interview, at a median of 3.5 years (range 2.3-6 years) after admission to the intensive care unit using a modification of the Glasgow Outcome Score (GOS) to assess functional outcome and the Health State Utility Index (Mark 1) to assess quality of life. MEASUREMENTS AND MAIN RESULTS: Of the children admitted to the intensive care unit, 83.8% were alive at the time of follow-up. While 10.3% of the survivors had an unfavourable outcome and were likely to live dependent on care, 89.7% had a favourable outcome and were likely to lead an independent existence. Although 16.4% had an unfavourable quality of life, 83.6% of the children survived with a favourable quality of life. At the time of follow-up, 16.2% of the children were dead: 49% died in the intensive care unit, 5% died in hospital and 46% died after discharge from hospital. CONCLUSIONS: The majority of children admitted to a paediatric intensive care unit survive with an excellent functional outcome and quality of life. Long-term outcome assessment provides a basis for observing trends in outcome over time within the same institution.
Authors: Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet Journal: Intensive Care Med Date: 2004-06-26 Impact factor: 17.440
Authors: Alicia K Au; Michael J Bell; Ericka L Fink; Rajesh K Aneja; Patrick M Kochanek; Robert S B Clark Journal: Neurocrit Care Date: 2018-02 Impact factor: 3.210
Authors: Elina Kyösti; Tero I Ala-Kokko; Pasi Ohtonen; Outi Peltoniemi; Paula Rautiainen; Janne Kataja; Hanna Ebeling; Janne H Liisanantti Journal: Intensive Care Med Date: 2018-08-22 Impact factor: 17.440
Authors: Kusum Menon; James Dayre McNally; Jerry J Zimmerman; Michael S D Agus; Katie O'Hearn; R Scott Watson; Hector R Wong; Mark Duffett; David Wypij; Karen Choong Journal: Pediatr Crit Care Med Date: 2017-03 Impact factor: 3.624
Authors: Matt S Zinter; Richard Holubkov; Martina A Steurer; Christopher C Dvorak; Christine N Duncan; Anil Sapru; Robert F Tamburro; Patrick S McQuillen; Murray M Pollack Journal: Biol Blood Marrow Transplant Date: 2017-11-08 Impact factor: 5.742